Vincristine |
Oncovin; Vincasar |
Vincristine Systematic (IUPAC) name ? Identifiers CAS number 57-22-7 ATC code L01CA02 PubChem 5978 DrugBank APRD00495 Chemical data Formula C46H56N4O10 Mol. weight 824.958 g/mol Pharmacokinetic data Bioavailability ? Protein binding ~75% Metabolism hepatic Half life 19-155 hours Excretion mostly biliary, 10% in urine Therapeutic considerations Pregnancy cat. ? Legal status ℞ Prescription only Routes ? Vincristine (Oncov ...
Wikipedia - [full article]
Vincristine News Headlines
- Study Showed Epratuzumab In Combination With Rituximab And Chemotherapy Is Safe, Tolerable, And Active In Aggressive Lymphoma
MedicalNewsToday - Tue, 05 Dec 2006 08:00 EST
- NICE Recommends Rituximab For The First Line Treatment Of Follicular Lymphoma, UK
MedicalNewsToday - Sat, 30 Sep 2006 08:00 EST
- Supplemental Biologics License Application For First-Line Use Of Rituxan In Low-Grade Or Follicular CD20-Positive B-Cell Non-Hodgkin's Lymphoma
MedicalNewsToday - Sat, 01 Apr 2006 11:00 EST

Not Signed In -


